Arkolith/Insider Trading/KURA/Form 4

Wilson Troy Edward

President and CEO, DirectorKura Oncology, Inc. (KURA) · full profile →Form 4 · filed Aug 14, 2025
Net Buying
Open-Market Buys
$303K
Open-Market Sells
$0
Net Open-Market Flow
$303K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 13, 2025Buy(P)13K$6.64$90K51K
Aug 12, 2025Buy(P)37K$5.85$214K37K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-108844) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML